Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,097 total articles
Nano Labs (NA) trades at roughly $46.7M market cap and just $2.01 per share, yet the company designs high-performance AI and vision chips and has several near-term catalysts (North America MOU, product launches, and CEO share buys). Technicals are mixed but sentiment and short interest suggest a squeeze potential. This trade idea lays out an action…
HEICO (HEI) combines high-margin aftermarket parts with a diversified electronics business. Recent beats in both Flight Support Group and Electronic Technologies Group, plus strong free cash flow ($944M), support continued EBITDA compounding. Valuation is rich (EV/EBITDA ~36x, P/E ~60x) so enter with a disciplined stop and a long-term horizon to le…
Standard Motor Products (SMP) looks inexpensive relative to its cash generation and recent acquisition-driven growth. Q1 2026 revenue of $451.2M (up 9.1% YoY), adjusted EBITDA of $44.5M and free cash flow of roughly $39.4M underpin a durable payout, an elevated dividend yield near 3.3% and an EV/EBITDA of ~8.2. For investors willing to accept modes…
Vicor makes high-density modular power systems that are suddenly mission-critical for AI datacenters. Strong Q1 results, a $301M backlog, and capacity expansion give near-term revenue visibility; the stock trades rich, but a controlled swing trade captures ongoing enterprise demand with clear stops and targets.
Element Solutions (ESI) supplies specialty chemicals critical to printed circuit boards and semiconductor packaging. With tight capacity and accelerating AI-related electronics demand, the stock is a practical way to play materials exposure to the AI cycle. Valuation looks fair relative to growth and technical setup, but execution and macro cycles …
Insmed (INSM) is a commercial-stage rare-disease biopharma with a deep TPIP (Treprostinil Palmitil Inhalation Powder) Phase 3 program. The stock has pulled back to $95.77 after a stretch of volatility, trading well off its $212.75 52-week high. Given the market cap of roughly $20.7B, solid liquidity metrics, and an active short base, we view the cu…
REGENXBIO's Duchenne muscular dystrophy data has re-centered the risk/reward. Market capitalization is modest at ~$456M while technical momentum and a falling short interest backdrop support a tactical long. This trade idea outlines an entry at $8.90, a $12.00 target, and a $7.20 stop for a mid-term swing (45 trading days) with clear catalysts and …
Volkswagen ADR (VWAGY) is trading at a strikingly low multiple (P/E ~7, P/B ~0.24) while offering a 4.6% dividend yield and a fresh ex-dividend event on 06/22/2026. For income-seeking value investors the combination of an attractive current yield and clear upside to the 52-week high ($12.83) creates a defined trade opportunity. The bear case — stru…
Butterfly Network is back near its 52-week high after a heavy-volume run. The company pairs a low-cost, whole-body portable ultrasound with expanding AI and software services. Recent margin improvement, a growing AI imaging narrative and regulatory tailwinds create a near-term setup for a momentum-driven swing trade. Valuation is rich relative to r…
Methanex is the world’s largest methanol supplier and is starting Q2 with meaningful pricing tailwinds. With management reporting Q1 Adjusted EBITDA of $220M, expected spot methanol at $500-$525/tonne in Q2, and a net-cash rebuilding trend, the company can convert higher realized prices into stronger cash flow. Technicals show the stock oversold an…
On Holding (ONON) pairs category-leading product innovation with expanding margins and improving FX-adjusted growth. At a $12.9B market cap and trading under $40, the stock offers an asymmetric trade: durable premium positioning versus an already-stretched valuation. We recommend a long position with defined entry, stop and target and a primary hor…
Karooooo (KARO) is a profitable telematics and fleet software platform showing mid-teens subscription growth, a meaningful annual dividend, and steady cash generation. At a $1.47B market cap and a P/E of ~25.7, the stock looks fairly valued relative to its growth profile. This trade idea advocates a long entry on a pullback, a defined stop, and a 1…
Kinder Morgan (KMI) offers roughly three times the S&P 500 yield today with a stable midstream business, improving cash flow and an attractive valuation versus its asset-backed profile. This trade idea outlines a mid-term long entry, precise stops and targets, and the catalysts and risks that matter to income-seeking, quality-oriented investors.
Eos Energy (EOSE) just flipped a key operational switch: commercial production at Thorn Hill, Battery Line 2 online and a growing commercial pipeline and backlog. The market has been skeptical, but the company is delivering the manufacturing milestones that remove a primary bottleneck. I recommend a tactical long with a mid-term horizon to capture …
Amazon is trading $244.37 after a pullback from its highs. With AWS growing into an AI infrastructure leader, a market cap near $2.63T, and a PE around 29x, the stock looks priced for slower growth than the company can deliver. This trade idea outlines an actionable long with precise entry, stop and target and a 180-trading-day horizon.
Johnson & Johnson ($JNJ) is a large-cap defensive compounder with a diversified MedTech and Innovative Medicine franchise, $17.4B in free cash flow, and a 2.3% yield. Recent positive Phase 3 data on TALVEY and continued margin resilience make JNJ an attractive buy to balance AI/concentrated-tech exposure. Initiate Buy with entry $228.40, target $26…
HubSpot trades at roughly $9.0B market cap with a P/E near 90 and EV/EBITDA around 37.6. Recent price action and guidance have left the market pricing an AI-driven acceleration that hasn't materialized in the metrics. Technicals show momentum loss and rising short interest. This trade proposes a mid-term short assuming the market re-rates HubSpot b…
Bassett (BSET) is a small-cap furniture maker and retailer trading at a deep valuation relative to its historical footprint. The stock yields ~5.1% and sits below tangible recovery levels despite improving technicals and signs of restructuring progress. This trade targets a move back toward the 52-week high while keeping a tight stop to respect ong…
Integra (IART) has gone from deep volatility to steady operational improvements. Q1 2026 showed revenue strength, margin expansion and higher adjusted EPS; management raised EPS guidance and installed Stuart Essig as CEO. The stock sits near $17.58 with a market cap of $1.37B and a path to re-rate if product relaunches and manufacturing fixes hit f…
Apple is leaning into higher average selling prices on the iPhone 18 cycle. That pricing power should buoy margins, drive services revenue through a more valuable installed base, and leave buyback-fueled EPS growth intact. This trade idea outlines a mid-term long with entry, stop and target levels and lays out catalysts and risks that could flip th…
Upstart has resumed profitability and is showing robust origination and revenue growth, but it still trades at a multiple that prices in continued execution. A mid-term (45 trading days) long with a tight stop offers an asymmetric way to participate in two near-term catalysts: bank charter progress and improving model performance.
Enbridge's tollbooth pipeline model, a secured $26.5B project backlog and a 5%+ yield make the stock a pragmatic long trade for income-focused investors. Valuation metrics look mixed — attractive yield and reasonable P/CF but a stretched P/FCF — so this is a measured, risk-managed long with a 180-trading-day horizon to let cash flow growth and proj…
Henry Schein (HSIC) looks positioned for another leg higher. Stable distribution cash flows, secular growth in clear aligners and a $200 million efficiency program combine with buybacks and improving technicals. Trade plan: enter $80.00, stop $73.00, target $92.00 over a mid-term horizon (45 trading days).
Conagra (CAG) is trading like a broken company while still generating meaningful free cash flow and sitting at valuation multiples that price in severe downside. The market is focused on near-term revenue erosion and dividend risk; that fear is real but overplayed. For disciplined buyers, a mid-term swing long with strict risk controls offers a fav…
Ultragenyx (RARE) fell sharply after Phase III failures for setrusumab and ensuing litigation. The stock has since stabilized around $27.40. With multiple marketed products, a $2.7B market cap and an enterprise value of ~$2.53B, the company looks like a reset case where investors can buy an established rare‑disease commercial platform without the e…
